These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 29789651)

  • 1. Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups.
    Bolli N; Biancon G; Moarii M; Gimondi S; Li Y; de Philippis C; Maura F; Sathiaseelan V; Tai YT; Mudie L; O'Meara S; Raine K; Teague JW; Butler AP; Carniti C; Gerstung M; Bagratuni T; Kastritis E; Dimopoulos M; Corradini P; Anderson KC; Moreau P; Minvielle S; Campbell PJ; Papaemmanuil E; Avet-Loiseau H; Munshi NC
    Leukemia; 2018 Dec; 32(12):2604-2616. PubMed ID: 29789651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling of multiple myeloma: New insights and modern technologies.
    Hultcrantz M; Yellapantula V; Rustad EH
    Best Pract Res Clin Haematol; 2020 Mar; 33(1):101153. PubMed ID: 32139018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma.
    Bolli N; Li Y; Sathiaseelan V; Raine K; Jones D; Ganly P; Cocito F; Bignell G; Chapman MA; Sperling AS; Anderson KC; Avet-Loiseau H; Minvielle S; Campbell PJ; Munshi NC
    Blood Cancer J; 2016 Sep; 6(9):e467. PubMed ID: 27588520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications.
    Cardona-Benavides IJ; de Ramón C; Gutiérrez NC
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma.
    Buedts L; Smits S; Ameye G; Lehnert S; Ding J; Delforge M; Vermeesch J; Boeckx N; Tousseyn T; Michaux L; Vandenberghe P; Dewaele B
    Genes Chromosomes Cancer; 2020 Aug; 59(8):465-471. PubMed ID: 32259320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
    Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
    Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic complexity of multiple myeloma and its clinical implications.
    Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
    Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
    Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
    Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
    BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.
    White BS; Lanc I; O'Neal J; Gupta H; Fulton RS; Schmidt H; Fronick C; Belter EA; Fiala M; King J; Ahmann GJ; DeRome M; Mardis ER; Vij R; DiPersio JF; Levy J; Auclair D; Tomasson MH
    Blood Cancer J; 2018 Mar; 8(3):35. PubMed ID: 29563506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.
    Kosztolányi S; Kiss R; Atanesyan L; Gángó A; de Groot K; Steenkamer M; Jáksó P; Matolcsy A; Kajtár B; Pajor L; Szuhai K; Savola S; Bödör C; Alpár D
    J Mol Diagn; 2018 Nov; 20(6):777-788. PubMed ID: 30096382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
    Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
    Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.
    Carrasco DR; Tonon G; Huang Y; Zhang Y; Sinha R; Feng B; Stewart JP; Zhan F; Khatry D; Protopopova M; Protopopov A; Sukhdeo K; Hanamura I; Stephens O; Barlogie B; Anderson KC; Chin L; Shaughnessy JD; Brennan C; Depinho RA
    Cancer Cell; 2006 Apr; 9(4):313-25. PubMed ID: 16616336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis.
    Soliman AM; Das S; Teoh SL
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma.
    Cutler SD; Knopf P; Campbell CJV; Thoni A; Abou El Hassan M; Forward N; White D; Wagner J; Goudie M; Boudreau JE; Kennedy BE; Gujar S; Gaston D; Elnenaei MO
    J Mol Diagn; 2021 Dec; 23(12):1699-1714. PubMed ID: 34562616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma.
    Kassambara A; Hose D; Moreaux J; Walker BA; Protopopov A; Reme T; Pellestor F; Pantesco V; Jauch A; Morgan G; Goldschmidt H; Klein B
    Haematologica; 2012 Apr; 97(4):622-30. PubMed ID: 22102711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and Novel Prognostic Biomarkers in Multiple Myeloma.
    Bustoros M; Mouhieddine TH; Detappe A; Ghobrial IM
    Am Soc Clin Oncol Educ Book; 2017; 37():548-560. PubMed ID: 28561668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis.
    Hou H; Zhang C; Qi X; Zhou L; Liu D; Lv H; Li T; Sun D; Zhang X
    Cancer Biol Ther; 2020; 21(1):26-33. PubMed ID: 31594446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
    Medina A; Jiménez C; Sarasquete ME; González M; Chillón MC; Balanzategui A; Prieto-Conde I; García-Álvarez M; Puig N; González-Calle V; Alcoceba M; Cuenca I; Barrio S; Escalante F; Gutiérrez NC; Gironella M; Hernández MT; Sureda A; Oriol A; Bladé J; Lahuerta JJ; San Miguel JF; Mateos MV; Martínez-López J; Calasanz MJ; García-Sanz R
    Blood Cancer J; 2020 Feb; 10(2):14. PubMed ID: 32029700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilizing next-generation sequencing in the management of multiple myeloma.
    Lionetti M; Neri A
    Expert Rev Mol Diagn; 2017 Jul; 17(7):653-663. PubMed ID: 28524737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.